LTGO
LTGO clinical trials: Latigo Biotherapeutics, Inc.
Every trial on ClinicalTrials.gov where Latigo Biotherapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 9
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
LTGO on the catalyst calendar · LTGO registry changes
- Primary completion Dec 24, 2026Sponsor estimatePhase 1NCT07915947LTG-321 - Itraconazole Drug-drug Interaction (DDI) StudyLatigo Biotherapeutics · PK Drug-drug Interaction StudyNot yet recruitingLTGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 8, 2026ActualPhase 1NCT07110610Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy ParticipantsLatigo Biotherapeutics · Healthy ParticipantsCompletedLTGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2026Sponsor estimatePhase 1NCT06049095A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy ParticipantsLatigo Biotherapeutics · HealthyActive, not recruitingLTGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 8, 2025ActualPhase 2NCT06774625This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third MolarsLatigo Biotherapeutics · Acute Pain, PostoperativeCompletedLTGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 7, 2026ActualPhase 2NCT07102459An Efficacy and Safety Study of LTG-001 Following AbdominoplastyLatigo Biotherapeutics · Acute PainCompletedLTGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 17, 2025ActualPhase 1NCT07341152A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy ParticipantsLatigo Biotherapeutics · Pain ManagementCompletedLTGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 28, 2025ActualEarly Phase 1NCT06972212Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male AdultsLatigo Biotherapeutics · Pain DetectionCompletedLTGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 16, 2025ActualPhase 1NCT06554574A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy ParticipantsLatigo Biotherapeutics · HealthyCompletedLTGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 27, 2024ActualEarly Phase 1NCT06600607Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male AdultsLatigo Biotherapeutics · Pain DetectionCompletedLTGOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner